Skip to main content
Have a personal or library account? Click to login
Evaluation of shRNA-mediated gene silencing by electroporation in LPB fibrosarcoma cells Cover

Evaluation of shRNA-mediated gene silencing by electroporation in LPB fibrosarcoma cells

Radiology and Oncology
Volume 42 (2008): Issue 2 (June 2008)
By: ,   and    
Open Access
|Jun 2008
References

References

  1. Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J. In vivo electrically mediated protein and gene transfer in murine melanoma.1998; 16(2): 168-71.
    Open DOISearch in Google Scholar
  2. Wells JM, Li LH, Sen A, Jahreis GP, Hui SW. Electroporation-enhanced gene delivery in mammary tumors.2000; 7(7): 541-7.
    Open DOISearch in Google Scholar
  3. Bettan M, Ivanov MA, Mir LM, Boissiere F, Delaere P, Scherman D. Efficient DNA electrotransfer into tumors.2000; 52(1): 83-90.
    Open DOISearch in Google Scholar
  4. Cemazar M, Sersa G, Wilson J, Tozer GM, Hart SL, Grosel A et al. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.2002; 9(4): 399-406.
    Open DOISearch in Google Scholar
  5. Cemazar M, Wilson I, Dachs GU, Tozer GM, Sersa G. Direct visualization of electroporation-assisted in vivo gene delivery to tumors using intravital microscopy - spatial and time dependent distribution.2004; 4(81.)
    Open DOISearch in Google Scholar
  6. Izquierdo M. Short interfering RNAs as a tool for cancer gene therapy.2005; 12(3): 217-27.
    Open DOISearch in Google Scholar
  7. Scherer L, Rossi JJ. Recent applications of RNAi in mammalian systems.2004; 5(4): 355-60.
    Open DOISearch in Google Scholar
  8. Pai SI, Lin YY, Macaes B, Meneshian A, Hung CF, Wu TC. Prospects of RNA interference therapy for cancer.2006; 13(6): 464-77.
    Open DOISearch in Google Scholar
  9. Dykxhoorn DM, Palliser D, Lieberman J. The silent treatment: siRNAs as small molecule drugs.2006; 13(6): 541-52.
    Open DOISearch in Google Scholar
  10. McAnuff MA, Rettig GR, Rice KG. Potency of siRNA versus shRNA mediated knockdown in vivo.2007; 96(11): 2922-30.
    Open DOISearch in Google Scholar
  11. Gottesman MM. Cancer gene therapy: an awkward adolescence.2003; 10(7): 501-8.
    Open DOISearch in Google Scholar
  12. Meyer M, Wagner E. Recent developments in the application of plasmid DNA-based vectors and small interfering RNA therapeutics for cancer.2006; 17(11): 1062-76.
    Open DOISearch in Google Scholar
  13. Grassi G, Maccaroni P, Meyer R, Kaiser H, D'Ambrosio E, Pascale E et al. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87.2003; 24(10): 1625-35.
    Open DOISearch in Google Scholar
  14. Krishnan M, Park JM, Cao F, Wang D, Paulmurugan R, Tseng JR et al. Effects of epigenetic modulation on reporter gene expression: implications for stem cell imaging.2006; 20(1): 106-8.
    Open DOISearch in Google Scholar
  15. Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ. Is green fluorescent protein toxic to the living cells?1999; 260(3): 712-7.
    Open DOISearch in Google Scholar
  16. Jana S, Chakraborty C, Nandi S, Deb JK. RNA interference: potential therapeutic targets.2004; 65(6): 649-57.
    Open DOISearch in Google Scholar
  17. Bantounas I, Phylactou LA, Uney JB. RNA interference and the use of small interfering RNA to study gene function in mammalian systems.2004; 33(3): 545-57.
    Open DOISearch in Google Scholar
  18. Behlke MA. Progress towards in vivo use of siRNAs.2006; 13(4): 644-70.
    Open DOISearch in Google Scholar
  19. Birmingham A, Anderson E, Sullivan K, Reynolds A, Boese Q, Leake D et al. A protocol for designing siRNAs with high functionality and specificity.2007; 2(9): 2068-78.
    Open DOISearch in Google Scholar
  20. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.2002; 16(8): 948-58.
    Open DOISearch in Google Scholar
  21. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells.2002; 296(5567): 550-3.
    Open DOISearch in Google Scholar
  22. Cullen BR. Induction of stable RNA interference in mammalian cells.2006; 13(6): 503-8.
    Open DOISearch in Google Scholar
  23. McManus MT, Petersen CP, Haines BB, Chen J, Sharp PA. Gene silencing using micro-RNA designed hairpins.2002; 8(6): 842-50.
    Open DOISearch in Google Scholar
  24. Xie FY, Woodle MC, Lu PY. Harnessing in vivo siRNA delivery for drug discovery and therapeutic development.2006; 11(1-2): 67-73.
    Open DOISearch in Google Scholar
  25. Russ V, Wagner E. Cell and tissue targeting of nucleic acids for cancer gene therapy.2007; 24(6): 1047-57.
    Open DOISearch in Google Scholar
  26. Sersa G, Cemazar M, Miklavcic D, Rudolf Z. Electrochemotherapy of tumours.2006; 40(3): 163-74.
    Search in Google Scholar
  27. Heller LC, Heller R. In vivo electroporation for gene therapy.2006; 17(9): 890-7.
    Open DOISearch in Google Scholar
  28. Tamura T, Sakata T. Application of in vivo electroporation to cancer gene therapy.2003; 3(1): 59-64.
    Open DOISearch in Google Scholar
  29. Cemazar M, Sersa G. Electrotransfer of therapeutic molecules into tissues.2007; 9(6): 554-62.
    Search in Google Scholar
  30. Fan Y, Xin XY, Chen BL, Ma X. Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo.2006; 38(6): 561-7.
    Search in Google Scholar
  31. Nakai N, Kishida T, Shin-Ya M, Imanishi J, Ueda Y, Kishimoto S et al. Therapeutic RNA interference of malignant melanoma by electrotransfer of small interfering RNA targeting Mitf.2007; 14(4): 357-65.
    Open DOISearch in Google Scholar
  32. Takei Y, Nemoto T, Mu P, Fujishima T, Ishimoto T, Hayakawa Y et al. In vivo silencing of a molecular target by short interfering RNA electroporation: tumor vascularization correlates to delivery efficiency.2008; 7(1): 211-21.
    Open DOISearch in Google Scholar
  33. Golzio M, Mazzolini L, Ledoux A, Paganin A, Izard M, Hellaudais L et al. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.2007; 14(9): 752-9.
    Open DOISearch in Google Scholar
  34. Takahashi Y, Nishikawa M, Kobayashi N, Takakura Y. Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases.2005; 105(3): 332-43.
    Open DOISearch in Google Scholar
  35. Takahashi Y, Nishikawa M, Takakura Y. Suppression of tumor growth by intratumoral injection of short hairpin RNA-expressing plasmid DNA targeting beta-catenin or hypoxia-inducible factor 1alpha.2006; 116(1): 90-5.
    Open DOISearch in Google Scholar
  36. Rejiba S, Wack S, Aprahamian M, Hajri A. K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment.2007; 98(7): 1128-36.
    Open DOISearch in Google Scholar
  37. Chiu YL, Rana TM. RNAi in human cells: basic structural and functional features of small interfering RNA.2002; 10(3): 549-61.
    Open DOISearch in Google Scholar
  38. Devi GR. siRNA-based approaches in cancer therapy.2006; 13(9): 819-29.
    Open DOISearch in Google Scholar
  39. Thomas M, Lu JJ, Ge Q, Zhang C, Chen J, Klibanov AM. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung.2005; 102(16): 5679-84.
    Open DOISearch in Google Scholar
  40. Grayson AC, Doody AM, Putnam D. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro.2006; 23(8): 1868-76.
    Open DOISearch in Google Scholar
  41. Merkerova M, Klamova H, Brdicka R, Bruchova H. Targeting of gene expression by siRNA in CML primary cells.2007; 34(1): 27-33.
    Open DOISearch in Google Scholar
  42. Bartlett DW, Davis ME. Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging.2006; 34(1): 322-33.
    Open DOISearch in Google Scholar
  43. Corish P, Tyler-Smith C. Attenuation of green fluorescent protein half-life in mammalian cells.1999; 12(12): 1035-40.
    Open DOISearch in Google Scholar
  44. Agami R. RNAi and related mechanisms and their potential use for therapy.2002; 6(6): 829-34.
    Open DOISearch in Google Scholar
  45. Caplen NJ. Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference.2004; 11(16): 1241-8.
    Open DOISearch in Google Scholar
  46. Ryther RC, Flynt AS, Phillips JA, III, Patton JG. siRNA therapeutics: big potential from small RNAs.2005; 12(1): 5-11.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-008-0007-3 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 82 - 92
Published on: Jun 11, 2008
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
electroporation,
plasmid DNA,
shRNA,
fibrosarcoma
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2008 Suzana Mesojednik, Urška Kamenšek, Maja Čemažar, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 42 (2008): Issue 2 (June 2008)
Previous article
Next article